Drugs from the Feds?

Published



At NRO, Scott Gottlieb writes, “Fresh off its successes in the green-energy patch, the Obama team is turning its investment skills to the life sciences. Last Friday, President Obama announced his intention to increase the federal government’s involvement in the business of biotechnology.” Gottlieb continues:  “[Obama’s] plan is for a new federal center inside the National Institutes of Health (NIH) that would be focused on the development and commercialization of new drugs.” Read the whole thing here.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.